Inflamação/metabolismo; Neoplasias/metabolismo; Transdução de Sinais; Receptores Toll-Like/metabolismo; Inflamação/genética; Modelos Moleculares; Mutação; Fator 88 de Diferenciação Mieloide/química; Fator 88 de Diferenciação Mieloide/genética; Fator 88 de Diferenciação Mieloide/metabolismo; Neoplasias/genética; Mapeamento de Interação de Proteínas/métodos; Mapas de Interação de Proteínas; Estrutura Terciária de Proteína; Receptores Toll-Like/química; Receptores Toll-Like/genética

Cancer; DAMPs; ECM; EGF; HMGB1; IAP; IBD; IFN-α; IFN-ß; IKK; IL-6; IRAK; IRFs; Inflammation; Inflammation and cancer link; IκB-kinase; LRR; MDSCs; Mal; MyD88; MyD88 adaptor-like; NF-κB; NSAIDs; PAMPs; PRISM; PRRs; PRotein Interactions by Structural Matching; PTEN; PTMs; RANK; ROS; SARM; Structural data; Structural pathway; T(reg)s; TAMs; TGF-ß; TIR; TIR domain containing adaptor inducing interferon-ß; TLR; TNF-α; TRAM; TRIF; TRIF-related adaptor molecule; Toll-like receptor; Toll/IL-1R; Ubc13; VEGF; VHL; damage-associated molecular patterns; epidermal growth factor; extracellular matrix; high mobility group box-1; inflammatory bowel disease; inhibitors of apoptosis; interferon alpha; interferon beta; interferon regulatory factors; interleukin-1 receptor-associated kinases; interleukin-6; leucine-rich repeats; myeloid differentiation factor 88; myeloid-derived suppressor cells; non-steroidal anti-inflammatory drugs; pathogen-associated molecular patterns; pattern recognition receptors; phosphatase and tensin homologue; post-translational modifications; reactive oxygen species; receptor activator of NF-κB; regulatory T cells; sterile α and heat-armadillo motifs; transforming growth factor-1 beta; tumor necrosis factor-alpha; tumor-associated macrophages; ubiquitin-conjugating enzyme E2N; vascular endothelial growth factor; von Hippel Lindau